echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Medical anti-corruption Central Commission for Discipline Inspection re-issued a message

    Medical anti-corruption Central Commission for Discipline Inspection re-issued a message

    • Last Update: 2020-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the official website of the Central Commission for Discipline Inspection of the Communist Party of China (CPC) once again published the important article "Taking cases as a mirror" 18 years of double-sided life with a knife in surgery.
    article exposed by the local people called the surgical "a knife" Wang, its use of office facilities to help agents in the hospital successfully get the value of 260 million yuan worth of drug supply rights, and receive drug benefits of more than 10 million yuan;
    As the title of the official website of the Central Commission for Discipline Inspection, "Taking cases as a mirror", since April this year, the Central Commission for Discipline Inspection has published a number of thematic articles and case reviews, sword refers to drug rebates, pharmaceutical commercial bribery and other issues.
    , especially since August, this is the fifth in just one month, the frequency is high enough to attract attention and vigilance.
    To this, Chongqing Doputai Pharmaceutical Promotion Minister Zhao Jiazhen told SaiBaiLan: Since this time, the National Health Care Commission, the State Health Insurance Administration and other relevant units have issued a lot of documents, especially for the field of health care anti-corruption and anti-corruption action;
    hospitals and doctors directly correspond to pharmaceutical companies, large-scale clean-up and anti-corruption activities, but also brought about a part of the impact of pharmaceutical enterprises.
    Zhao Jiazhen said: because of the epidemic, the first quarter of the first half of the year to April, many pharmaceutical representatives of the promotion work can not be carried out, I would like to through the second and third quarters of a large area of offline promotion to make up for the loss of sales;
    he further admitted: at present, it is understood that many hospitals from the inside issued documents, doctors and customers made it clear that now medical representatives are best not to go to the hospital face-to-face visit.
    after all, this time the inspection is relatively strong, will certainly catch some typical.
    hospital does not want to have any related bad behavior.
    of the medical representatives, the impact is greater? In part, hospital visits by medical representatives are restricted due to increased efforts to clean up the air, but for different medical representatives, there are varying degrees of impact.
    Zhao Jiazhen admitted: in the hospital has fixed clinical resources and customer resources of the old representative, will not have much impact, after all, doctors have developed the inertia of clinical drug use products.
    just a few strange visits, and the new representatives who are just starting to develop the hospital, the pressure will be even greater.
    , but in general, the Central Commission for Discipline Inspection's review of medical anti-corruption efforts will become the norm in the future.
    The above-mentioned professionals predict that: pharmaceutical representatives of the gold work, whether from the national collection or compliance level will be depressed, so the future work of pharmaceutical representatives will be in compliance direction transformation, do more related to the market academic promotion work, less guest maintenance, so as to avoid the impact on their future professional work.
    the future, medical representatives will face several pressures: First, the national collection.
    after the collection of the entire drug profits are compressed, will have a great impact on the promotion costs of pharmaceutical representatives, and even some have entered the collection of varieties, has been cancelled the post of pharmaceutical representatives and promotion;
    pharmaceutical enterprises must set up a professional marketing team, the previous traditional, only the way of customer-friendly and gold-based marketing team into customer and academic promotion of the marketing team.
    , medical representatives need to improve their knowledge of medicine and medicine, and even master how to use the transfer of academic promotion projects to drive sales marketing.
    the main difference between the pharmaceutical representatives of foreign-funded enterprises and the representatives of domestic pharmaceutical enterprises? The first is the poor hardware conditions of the knowledge level, and the second is that there is no complete system of meetings and projects to deliver content.
    " Zhao Jiazhen said that more medical representatives and doctors to talk about product knowledge level things, the use of manufacturers' academic promotion resources, to follow up meetings, projects, so as to achieve the purpose of academic promotion, which is the future of pharmaceutical representatives of the necessary skills.
    this time, due to the high-pressure state of anti-corruption medicine, many reports of letters have also been frequently reported by the media, pointing directly to some department doctors and pharmaceutical representatives there is an abnormal sales relationship.
    Zhao Jiazhen told Cypress: In fact, every year there are similar reports, but in recent years, the media exposure amplified this matter, medical representatives do not need to panic.
    the core lies in their own fission, the formation of professional clinical team, to the formal academic promotion of the clinical team transformation, is the fundamental way to solve this problem in the future.
    With the promotion of national procurement, the pharmaceutical industry tax verification, coupled with strict inspection of drug rebates as an auxiliary, multi-pronged, the past through the middle link with gold to pull the sale of traditional drug marketing methods completely out of reach, pharmaceutical companies must wake up, compliance and transformation to solve the fundamental problem.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.